“Eugenics” implies intent, which is difficult to prove. However the alternative is that the left hand of medicine doesn’t know what the right hand is doing. Let me put it this way: it’s inconceivable that a sizable fraction of medical researchers are not aware of this issue. Who is minding the store?
African Americans suffer asthma more often and more severely than Caucasian patients. However, clinical trials that have shaped treatment guidelines have included few African Americans. A new report demonstrates a shortcoming of that history. Researchers at National Jewish Health and their colleagues around the nation in the National Heart, Lung & Blood Institute’s AsthmaNet report that African American children respond differently than African American adults and Caucasian adults and children to step-up therapies for inadequately controlled asthma.
“Asthma is a tremendously variable disease,” said Michael Wechsler, MD, professor of medicine at National Jewish Health and first author on the study published in the New England Journal of Medicine. “We need to more closely study subgroups of asthma patients, especially those disproportionately burdened by disease, such as African Americans.”…
More adult African Americans responded better to adding long-acting beta agonists (49 percent) versus increasing inhaled steroids alone (28 percent). Caucasians have shown a similar response in previous trials.
However, even numbers of African American children responded better to increasing the dose of inhaled corticosteroids along (46 percent) and adding long-acting beta agonists (46 percent).
“These results indicate that asthma treatment guidelines do not necessarily apply to African American children and that physicians should consider alternatives,” said Dr. Wechsler. “We need to do a better job of understanding how different subgroups respond to asthma treatment.”
The researchers also looked at several biological and genetic factors to determine if any could predict treatment response. However, they did not find that any biomarkers or percentage of African American ancestry was associated treatment response.
The eugenic connection is evident when you consider the effort that it must take to overlook the fact that black people tend to be deficient in vitamin D due to their skin pigmentation. Apparently this is over the heads of our “public health” establishment.
Each day, eleven Americans die from asthma. The death rate for children under 19 years of age has increased by 80% percent since 1980. More females die of asthma than males, with women accounting for 65% of all asthma deaths. African-Americans are three times more likely to die from asthma than Caucasians.
If you or your child has asthma, you should take adequate amounts of vitamin D because so much scientific evidence shows it will help. The evidence that vitamin D will help childhood asthma is stronger than for adult asthma, but both adult and childhood asthmatics should take adequate daily doses of vitamin D. Children often respond in several months, but it may take several years for adult asthmatics to respond. It is crucial that asthmatics take high enough doses of vitamin D, as low doses, such as 1,000 or 2,000 IU/day, may not give as strong a treatment effect. In addition, it is important to continue supplementing with vitamin D on an ongoing basis; if you stop, your vitamin D levels will fall, and your asthma may flare up.
The most recent clinical trial of vitamin D and asthma, published in the highly respected journal, Chest (Alansari et al, 2017) found vitamin D reduced flare ups of asthma by a whopping 300% in children, while a much larger study found a vitamin D like compound reduced asthma flare up by 74% in children. In adults, another 2017 study (Ali et al, 2017, Ann Allergy Astma Immunol.) found that a vitamin D drug significantly reduced asthma severity and improved tests of lung function. Another 2018 study found vitamin D reduced respiratory events but not until the second year of treatment (Lee 2018 Blood Adv.).
Very high doses of vitamin D, i.e. 50,000 IU per day for three months, resulted in significant improvements in asthma patients by the second month (Babar, 2017, Pak J Med Sci). In 2017, a study found asthma exacerbations reduced with long-term vitamin D replacement (Solidoro, 2017, Nutrients). The most respected review in Medicine, the Cochrane meta-analysis (compilation of multiple studies), concluded vitamin D reduced asthma flareups (Jolliffe, 2017, Lancet Respir Med.). Another meta-analysis by Autier, a vocal vitamin D critic, found vitamin D reduced both asthma attacks and respiratory infections (Autier et al, 2017, Lancet Diabetes Endocrinol).
As every asthmatic knows, a cold or the flu usually causes asthma to flare up. Anything that reduces the chance of developing a cold or flu will reduce asthmatic symptoms. In 2017, a Cochrane meta-analysis (Martineu et al, 2017, BMJ), which is the strongest proof in medicine, found vitamin D significantly reduced colds and flu.
These, and other studies, were positive, despite using inadequate amounts of vitamin D. When one examines studies using adequate doses, they find vitamin D not only improves asthma symptoms, but also reduces the risk of colds and flu. Vitamin D supplement doses are considered adequate when they increase vitamin D levels into the ideal range (40-80 ng/ml; 100-200 nmol/l). For asthmatic children, that dose is 1,000 IU/day for every 25 pounds of body weight. Asthmatic adults usually need between 10,000 IU/day and 15,000 IU/day. However, as when treating any disease with vitamin D, the important number is your vitamin D blood level number. It should be higher than 50 ng/ml….
A different mechanism of eugenical selection, this one based on the correlation between access to breast milk and socioeconomic factors such as stay-at-home moms and workplace allowances for BF. Other primates have no such issues because they have no medical establishment which normalizes and encourages (via obstetrical protocols and hospital “new baby” free samples https://banthebags.org/48/ ) formula feeding.
Correlations between skin color and socioeconomic status are also evident here. The “hidden hand” of the “free market” has spoken.
Breastfeeding and childhood asthma: systematic review and meta-analysis.
Asthma and wheezing disorders are common chronic health problems in childhood. Breastfeeding provides health benefits, but it is not known whether or how breastfeeding decreases the risk of developing asthma. We performed a systematic review and meta-analysis of studies published between 1983 and 2012 on breastfeeding and asthma in children from the general population. We searched the PubMed and Embase databases for cohort, cross-sectional, and case-control studies. We grouped the outcomes into asthma ever, recent asthma, or recent wheezing illness (recent asthma or recent wheeze). Using random-effects meta-analyses, we estimated pooled odds ratios of the association of breastfeeding with the risk for each of these outcomes. We performed meta-regression and stratified meta-analyses. We included 117 of 1,464 titles identified by our search. The pooled odds ratios were 0.78 (95% confidence interval: 0.74, 0.84) for 75 studies analyzing “asthma ever,” 0.76 (95% confidence interval: 0.67, 0.86) for 46 studies analyzing “recent asthma,” and 0.81 (95% confidence interval: 0.76, 0.87) for 94 studies analyzing recent wheezing illness. After stratification by age, the strong protective association found at ages 0-2 years diminished over time. We found no evidence for differences by study design or study quality or between studies in Western and non-Western countries. A positive association of breastfeeding with reduced asthma/wheezing is supported by the combined evidence of existing studies….